This invention was made with government support under grant EB002520 awarded by the National Institutes of Health. The government has certain rights in the invention.
In some embodiments, the present invention provides, inter alfa, biologically-matched, programmable hydrogel ionic circuits were developed and delivered localized electrical stimulation in biological environments.
An increasing need for wearable and implantable medical devices has driven the demand for electronics that interface with living systems. Recent advances in materials research have enabled the development of more flexible and biocompatible electronic systems for wearable and implantable biomedical applications. However, existing rigid electron conductor-based electronic systems exhibit fundamental mismatches with biological systems. For example, conductive materials used in these bioelectronic devices usually exploit metals, carbon-based materials and conductive polymers. Most of these materials exhibit good biocompatibility and flexibility, but possess fundamental limitations with regard to stretchability and transparency; requiring specialized material designs (e.g., high aspect ratio nanomaterials, specially formulated conductive polymers) or device architectures (e.g., ultrathin coatings, serpentine circuit design) to achieve desired properties. Such requirements significantly increase design complexity, occupy device real estate, and can fundamentally affect the conductivity of the device. Moreover, most existing conductive materials exhibit a mechanical mismatch with human tissues, making them unsuitable for long-term wear and implantable applications. Most importantly, all of the conductive materials used in the devices carry electron currents (in some cases, hole currents), which have to be converted to ion currents at the electrode/electrolyte interfaces through electrochemical reactions in order to deliver stimulation to biological systems. This process inevitably induces local heat (through Joule heating), pH changes, electrode degradation, and the generation of highly reactive chemical species. These reactions can cause pain and damage to biological tissues, an issue especially relevant for long term or high current electrostimulation, such as in applications in neuromuscular stimulation, transcranial direct current stimulation, electroporation, iontophoresis, wound treatment, pain management, and defibrillation. Thus, new options for materials and devices are needed to facilitate a new generation of bio-compatible electronic systems that can avoid heat, reduce adverse biological effects, and prevent local degradation.
The present disclosure relates to programmable hydrogel ionic circuits having properties that are advantageous for use in biological systems. In particular, provided herein are programmable hydrogel ionic circuit that exhibit transparency, stretchability, aqueous-based connective interfaces, high-resolution routing of ionic currents between engineered and biological systems, and reduced tissue damage from electrochemical reactions. As described herein, the programmable hydrogel ionic circuits are produced using a combination of microfluidics and aqueous two-phase systems.
In a first aspect, provided herein is a hydrogel ionic circuit, the circuit comprising or consisting essentially of a molded, crosslinked polyethylene glycol (PEG) hydrogel polymer comprising at least two electrode channels separated by a gap, wherein the channels comprise a salt solution; and at least two ports to connect the salt solution electrode channels to a power source. The PEG hydrogel polymer can comprise at least 15% by weight of a high molecular weight PEG. The PEG hydrogel polymer can comprise at least 20% by weight of a high molecular weight PEG. The PEG can be polyethylene glycol dimethacrylate molecular weight 8,000 (PEGMA 8 k). The PEG hydrogel polymer can additionally comprise at least 15% by weight of a low molecular weight PEG. The PEG hydrogel can comprise at least 20% by weight of polyethylene glycol diacrylate molecular weight 700 (PEGDA 700). The salt solution can be a sodium sulfate (Na2SO4) solution or a sodium phosphate (Na2HPO4) solution. The salt solution can be a saturated salt solution. The circuit can additionally comprise an electronically responsive component, wherein, when a voltage difference is applied between the salt solution electrode channels, an induced current will activate the electronically responsive component. The electronically responsive component can be a light emitting diode (LED) or organic light emitting diode (OLED). The circuit can additionally comprise one or more cells in the gap between the at least two electrode channels. In some cases, at least two faces of the circuit are covered to prevent water evaporation, wherein the ports extend through the cover. The cover can be an electrical insulating material. The circuit can be optically transparent. The circuit can be stretchable. The circuit can additionally comprise an aqueous-based connective interface at the gap between the salt solution electrode channels.
In another aspect, provided herein is a device comprising one or more hydrogel ionic circuits of this disclosure and a power source. The device can comprise a light-emitting diode (LED) or organic light emitting diode (OLED). The device can comprise an aqueous-based connective interface at the gap between the salt solution electrode channels in the circuit.
In a further aspect, provided herein is a method of stimulating tissue comprising or consisting essentially of the steps of: contacting the aqueous-based connective interface of a circuit of this disclosure to a tissue; and applying a voltage difference across the salt solution electrode channels of the circuit, whereby the induced current stimulates the tissue. The tissue can be a tissue in a subject and the circuit is implanted into the subject. The circuit can be incorporated into a device additionally comprising a power source.
In another aspect, provided herein is a method for fabricating a hydrogel ionic circuit comprising or consisting essentially of the steps of: providing a solution comprising at least 15% by weight of a high molecular weight PEG and between about 0.005% and about 5.0% by weight of a photoinitiator on a mold with a raised or grooved channel pattern; photocrosslinking the high molecular weight PEG by exposure to ultra-violet (UV) light to form a PEG hydrogel with a channel pattern; bonding the PEG hydrogel with a channel pattern to a flat PEG hydrogel by exposure to UV light; and introducing a salt solution into channels of the PEG hydrogel via a port. The solution can comprise at least 20% by weight of a high molecular weight PEG. The high molecular weight PEG can be polyethylene glycol dimethacrylate molecular weight 8,000 (PEGMA 8 k). The solution can additionally comprise at least 15% by weight of a low molecular weight PEG. The solution can comprise at least 20% by weight of polyethylene glycol diacrylate molecular weight 700 (PEGDA 700). The salt solution can be a sodium sulfate (Na2SO4) solution or a sodium phosphate (Na2HPO4) solution. The salt solution can be a saturated salt solution. The photo-initiator can be selected from the group consisting of 2-hydroxy-1-(4-(hydroxyethoxy)phenyl)-2-methyl-1-propanone and dimethoxy-2-phenyl-acetophenone. One or more light-emitting diodes (LEDs) can be added between the PEG hydrogel with a channel pattern and the flat PEG hydrogel prior to bonding.
The patent or patent application file contains at least one drawing in color. Copies of this patent or patent application publication with color drawings will be provided by the Office upon request and payment of the necessary fee.
All of the patents and publications referred to herein are incorporated by reference in their entirety.
The methods and compositions disclosed herein are based at least in part on the inventors' development of salt/polyethylene glycol aqueous two-phase systems to fabricate programmable hydrogel ionic circuits. High-conductivity salt-solution-patterns were stably encapsulated within polyethylene glycol hydrogels using salt/polyethylene glycol phase separation to enable designer electronics tailored to display traits matched to biological systems. These include transparency, stretchability, complete aqueous-based connective interface, high-resolution routing of ionic current between engineered and biological systems, and reduced tissue damage from electrochemical reactions. The potential of such systems was demonstrated by generating a series of functional devices, including multi-pixel light-emitting diode displays, mechanically-adaptable circuits, skin-mounted electronics, and stimulators that delivered localized current to in vitro neuron cultures and in vivo muscles in live animals. Such electronic platforms may form the basis of interlaced, bioelectronic systems into the future.
Herein, aspects of the present invention provide aqueous-stable, hydrogel ionic circuits that were fabricated using a combination of microfluidics and aqueous two-phase systems (ATPS, the phase separation between polyethylene glycol and incompatible salts in aqueous environment). These hydrogel ionic circuits are transparent, stretchable and the circuit design of ionically conductive patterns can be mechanically re-programmed after the circuits are fabricated. Furthermore, certain aspects of the present invention demonstrate the utility of these hydrogel ionic circuits in delivering localized electrical stimulation in biological environments with reduced adverse effects when compared to conventional metal- and carbon-based electrodes.
In some embodiments, new hydrogel ionic circuits were developed based on ATPS, a phenomenon discovered more than one century ago, and used primarily for biomolecule separation and purification (20-22). Polyethylene glycol (PEG) is commonly used in ATPS, which can phase separate with various salts, such as sodium sulfate and sodium phosphate (23, 24). The PEG and salt are mixed together in an aqueous solution and centrifuged to allow the two phases to separate. Once the two-phase system forms, the PEG-rich phase has a low salt content and thus low ionic conductivity, while the salt-rich phase is highly conductive. To generate hydrogel ionic circuits based on salt/PEG ATPS, microchannels having desired conductive patterns were molded into photocrosslinked PEG hydrogels using polydimethylsiloxane (PDMS) molds (
In some embodiments, two phase separation can be important in certain provided hydrogel ionic circuits is the two-phase separation, which is dependent on the species of salt, the molecular weight of PEG and the concentrations of PEG and salt. We have tested the two-phase formation and long-term stability using different PEG polymers and salt-containing media by soaking the PEG hydrogels in media and monitoring their resistivity. A higher PEG concentration led to more stable two-phase separation with higher resistivity contrast between PEG hydrogels and salt media (
It will be understood by one of skill in the art that any PEG capable of two-phase separation can be used for the hydrogel ionic circuits and methods provided herein. For instance, PEGs having a molecular weight between about 600 to about 8,000 (e.g., having a MW of about 600, 650, 700, 800, 900, 1000, 1200, 1400, 1600, 1800, 2000, 3000, 4000, 5000, 6000, 7000, 8000 g/mol, inclusive) have been used to form aqueous two-phase systems. By way of non-limiting example, the Examples demonstrate embodiments using PEGs having molecular weights of 700 and 8,000.
It will be understood by one of skill in the art, that changes in resistivity for various tunable circuits may be desired. Therefore, the concentration of the salt solution used in the channels of the hydrogel circuit may be variable. Salts for use in the salt solution include, but are not limited to, sodium chloride (NaCl), sodium sulfate (Na2SO4), sodium phosphate (Na2HPO4), magnesium chloride (MgCl2), potassium bromide (KBr), and the like. Among different media, sodium sulfate and dibasic phosphate salt solutions were more efficient for two-phase formation using some of the PEG hydrogels described herein. With cell culture medium or Tyrode's solution (a buffer used for cellular electrical stimulation), higher concentration and lower molecular weight of PEG were required for stable phase separation. Because saturated sodium sulfate solution has the highest resistivity contrast with the PEG hydrogels tested, we chose to use this as the salt phase for Examples described below, unless otherwise noted.
In some embodiments, the PEG hydrogels include at least about 15%, at least about 20%, at least about 25%, or at least about 30% by weight of a high molecular weight PEG. As used herein, “high molecular weight PEG” refers to a polyethylene glycol with a molecular weight greater than 5 kDa (i.e., 5,000 g/mol). For incorporation into photo-crosslinked hydrogels, the high molecular weight PEG is functionalized with one more terminal acrylate groups which are polymerizable by photo-crosslinking. The PEG acrylate may be a PEG diacrylate (PEGDA) or a PEG dimethacrylate (PEGDMA). In some embodiments, the high molecular weight PEG for use in the PEG hydrogel is PEG dimethacrylate, molecular weight 8,000 (PEGDMA 8 k).
In some embodiments, the PEG hydrogels additionally include at least about 15%, at least about 20%, at least about 25%, at least about 30%, at least about 35%, at least about 40%, or at least about 45% by weight of a low molecular weight PEG. As used herein, “low molecular weight PEG” refers to a polyethylene glycol with a molecular weight less than 1,000 g/mol. For incorporation into photo-crosslinked hydrogels, the low molecular weight PEG is functionalized with one more terminal acrylate groups which are polymerizable by photo-crosslinking. The PEG acrylate may be a PEG diacrylate (PEGDA) or a PEG dimethacrylate (PEGDMA). In some embodiments, the low molecular weight PEG for use in the PEG hydrogel is PEG diacrylate, molecular weight 700 (PEGDA 700).
In some embodiments, the hydrogel comprises a biodegradable polymer. As used herein, the term “biodegradable” is used to refer to materials (e.g., polymers) that will degrade over time by the action of enzymes, by hydrolytic action, and/or by other similar mechanisms in the human body. In some cases, biodegradable hydrogels, when introduced into cells or tissues, are broken down by cellular machinery (e.g., enzymatic degradation) or by hydrolysis into components that cells or tissues can either reuse or dispose of without significant toxic effect(s). In certain embodiments, components generated by breakdown of a biodegradable material do not induce inflammation and/or other adverse effects in vivo. In some embodiments, biodegradable materials are enzymatically broken down. For example, a hydrogel can be biodegradable through the use of enzyme labile crosslinkers. Alternatively or additionally, in some embodiments, biodegradable materials are broken down by hydrolysis. In some embodiments, biodegradable polymeric materials break down into their component and/or into fragments thereof (e.g., into monomeric or submonomeric species). In some embodiments, breakdown of biodegradable materials (including, for example, biodegradable polymeric materials) includes hydrolysis of ester bonds. In some embodiments, breakdown of materials (including, for example, biodegradable polymeric materials) includes cleavage of urethane linkages.
Exemplary biodegradable polymers include, for example, polymers of hydroxy acids such as lactic acid and glycolic acid, including but not limited to poly(hydroxyl acids), poly(lactic acid)(PLA), poly(glycolic acid)(PGA), poly(lactic-co-glycolic acid)(PLGA), and copolymers with PEG, polyanhydrides, poly(ortho)esters, polyesters, polyurethanes, poly(butyric acid), poly(valeric acid), poly(caprolactone), poly(hydroxyalkanoates, poly(lactide-co-caprolactone), blends and copolymers thereof. Many naturally occurring polymers are also biodegradable, including, for example, proteins such as silk, albumin, collagen, gelatin and prolamines, for example, zein, and polysaccharides such as alginate, cellulose derivatives and polyhydroxyalkanoates, for example, polyhydroxybutyrate blends and copolymers thereof. Those of ordinary skill in the art will appreciate or be able to determine when such polymers are biocompatible and/or biodegradable derivatives thereof (e.g., related to a parent polymer by substantially identical structure that differs only in substitution or addition of particular chemical groups as is known in the art).
In some embodiments, the elastomeric property of PEG hydrogel materials allows the dimensions of the salt solution channels to be altered by external forces (
Any method known to one skilled in the art for cross-linking can be used for preparing the hydrogels. In some cases, polymerized using photo-cross-linking methods. Photoinitiators produce reactive free radical species that initiate the cross-linking and/or polymerization of monomers upon exposure to light. Any photoinitiator can be used in the cross-linking and/or polymerization reaction.
In some embodiments, the photoinitiator can be a peroxide (for example, ROOR′), a ketone (for example, RCOR′), an azo compound (i.e. compounds with a —N═N— group), an acylphosphineoxide, a sulfur-containing compound, a quinone. Exemplary photoinitiators include, but are not limited to, acetophenone; anisoin; anthraquinone; anthraquinone-2-sulfonic acid, sodium salt monohydrate; (benzene) tricarbonylchromium; 4-(boc-aminomethyl)phenyl isothiocyanate; benzin; benzoin; benzoin ethyl ether; benzoin isobutyl ether; benzoin methyl ether; benzoic acid; benzophenyl-hydroxycyclohexyl phenyl ketone; 3,3′,4,4′-benzophenonetetracarboxylic dianhydride; 4-benzoylbiphenyl; 2-benzyl-2-(dimethylamino)-4′-morpholinobutyrophenone; 4,4′-bis(diefhylamino)benzophenone; 4,4′-bis(dimethylamino)benzophenone; Michler' s ketone; camphorquinone; 2-chlorothioxanthen-9-one; 5-dibenzosuberenone; (cumene)cyclopentadienyliron(II) hexafluorophosphate; dibenzosuberenone; 2,2-diefhoxyacetophenone; 4,4′-dihydroxybenzophenone; 2,2-dimethoxy2-phenylacetophenone; 4-(dimethylamino)benzophenone; 4,4′-dimethylbenzyl; 2,5-dimethylbenzophenone; 3,4-dimethylbenzophenone; diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide; 2-hydroxy-2-methylpropiophenone; 4′-ethoxyacetophenone; 2-ethylanthraquinone; ferrocene; 3′-hydroxyacetophenone; 4′-hydroxyacetophenone; 3-hydroxybenzophenone; 4-hydroxybenzophenone; 1-hydroxycyclohexyl phenyl ketone; 2-hydroxy-2-methylpropiophenone; 2-methylbenzophenone; 3-methyl benzophenone; methybenzoylformate; 2-methyl-4′-(methylthio)-2-morpholinopropiophenone; 9,10-phenanthrenequinone; 4′-phenoxyacetophenone; thioxanthen-9-one; triarylsulfonium hexafluoroantimonate salts; triarylsulfonium hexafluorophosphate salts; 3-mercapto-1-propanol; 11-mercapto-1-undecanol; 1-mercapto-2-propanol; 3-mercapto-2-butanol; hydrogen peroxide; benzoyl peroxide; 4,4′-dimethoxybenzoin; 2,2-dimethoxy-2-phenylacetophenone; dibenzoyl disulphides; diphenyldithiocarbonate; 2,2′-azobisisobutyronitrile (AIBN); camphorquinone (CQ); eosin; dimethylaminobenzoate (DMAB); dimethoxy-2-phenyl-acetophenone (DMPA); Quanta-cure ITX photosensitizes (Biddle Sawyer); Irgacure 907 (Ciba Geigy); Irgacure 2959 (CIBA Geigy); Irgacure 651 (Ciba Geigy); Darocur 2959 (Ciba Geigy); ethyl-4-N,N-dimethylaminobenzoate (4EDMAB); 1-[-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan1-one; 1-hydroxy-cyclohexyl-phenyl-ketone; 2,4,6trimethylbenzoyldiphenylphosphine oxide; diphenyl(2,4,6trimethylbenzoyl)phosphine; 2-ethylhexyl-4 dimethylaminobenzoate; 2-hydroxy-2-methyl-1-phenyl-1-propanone; 65% (oligo[2-hydroxy-2-methyl-1-[4-(1methylvinyl)phenyl]propanone] and 35% propoxylated glyceryl triacrylate; benzil dimethyl ketal; benzophenone; blend of benzophenone and a-hydroxy-cyclohexyl-phenylketone; blend of Esacure KIP150 and Esacure TZT; blend of Esacure KIP150 and Esacure TZT; blend of Esacure KIP150 and TPGDA; blend of phosphine oxide, Esacure KIP150 and Esacure TZT; difunctional a-hydroxy ketone; ethyl 4-(dimethylamino)benzoate; isopropyl thioxanthone; 2-hydroxy-2methyl-phenylpropanone; 2,4,6,-trimethylbenzoyldipheny-1-phosphine oxide; 2,4,6-trimethyl benzophenone; liquid blend of 4-methylbenzophenone and benzophenone; oligo(2-hydroxy-2-methyl-1-(4(1-methylvinyl)phenyl)propanone; oligo(2-hydroxy-2-methyl-1-4(1-methylvinyl)phenyl propanone and 2-hydroxy-2-methyl-1-phenyl-1-propanone (monomeric); oligo(2-hydroxy-2-methyl-1-4(1-methylvinyl)phenyl propanone and 2-hydroxy-2-methyl-1-phenyl-1-propanone (polymeric); 4-methylbenzophenone; trimethylbenzophenone and methylbenzophenone; and water emulsion of 2,4,6-trimethylbenzoylphosphine oxide, alpha hydroxyketone, trimethylbenzophenone, and 4-methyl benzophenone. In certain embodiments, the photoinitiator is acetophenone; diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide; 4,4′-dimethoxybenzoin; anthraquinone; anthraquinone-2-sulfonic acid; benzene-chromium(O) tricarbonyl; 4-(boc-aminomethyl)phenyl isothiocyanate; benzil; benzoin; benzoin ethyl ether; benzoin isobutyl ether; benzoin methyl ether; benzophenone; benzoic acid; benzophenone/1 hydroxycyclohexyl phenyl ketone, 50/50 blend; benzophenone-3,3′,4,4′-tetracarboxylic dianhydride; 4-benzoylbiphenyl; 2-benzyl-2-(dimethyl amino)-4′ morpholinobutyrophenone; 4,4′-bis(diethylamino) benzophenone; Michler' s ketone; (±)-camphorquinone; 2-chlorothioxanthen-9-one; 5-dibenzosuberenone; 2,2-diethoxyacetophenone; 4,4′-dihydroxybenzophenone; 2,2-dimethoxy-2-phenylacetophenone; 4-(dimethylamino)benzophenone; 4,4′-dimethylbenzil; 3,4dimethylbenzophenone; diphenyl (2,4,6-trimethylbenzoyl) phosphine oxide/2-hydroxy methylpropiophenone; 4′-ethoxyacetophenone; 2-ethylanthraquinone; ferrocene; 3′-hydroxyacetophenone; 4′-hydroxyacetophenone; 3-hydroxybenzophenone; 4-hydroxybenzophenone; 1-hydroxycyclohexyl phenyl ketone; 2-hydroxy-2-methylpropiophenone; 2-methylbenzophenone; 3-methylbenzophenone; methyl benzoylformate; 2-methyl-4′-(methylthio)-2-morpholinopropiophenone; 9,10-phenanthrenequinone; 4′-phenoxyacetophenone; thioxanthen-9-one; triarylsulfonium hexafluorophosphate salts; 3-mercapto-1-propanol; 11-mercapto-1-undecanol; 1-mercapto-2-propanol; and 3-mercapto-2-butanol, all of which are commercially available from Sigma-Aldrich. In certain embodiments, the free radical initiator is selected from the group consisting of benzophenone, benzyl dimethyl ketal, 2-hydroxy-2-methyl-phenylpropanone; 2,4,6-trimethylbenzoyldiphenyl phosphine oxide; 2,4,6-trimethyl benzophenone; oligo(2-hydroxy-2-methyl-1 (4-(1-methylvinyl)phenyl)propanone and 4-methylbenzophenone. In some embodiments, the photoinitiator is dimethoxy-2-phenyl-acetophenone (DMPA), a titanocene, 2-hydroxy-1-(4(hydroxyethoxy)phenyl)-2-methyl-l-propanone, Igracure.
In some embodiments, the initiator is 2-hydroxy-1-(4-(hydroxyethoxy)phenyl)-2-methyl-1-propanone (Irgacure 2959, CIBA Chemicals).
In general, photoinitiators are utilized at concentrations ranging between approximately 0.005% w/v and 5.0% w/v. For example, photoinitiators can be utilized at concentrations of about 0.005% w/v, about 0.01% w/v, about 0.025% w/v, about 0.05% w/v, about 0.075% w/v, about 0.1% w/w, about 0.125% w/v, about 0.25% w/v, about 0.5% w/v, about 0.75% w/v, about 1% w/v, about 1.125% w/v, about 1.25% w/v, about 1.5% w/v, about 1.75% w/v, about 2% w/v, about 2.125% w/v, about 2.25% w/v, about 2.5% w/v, about 2.75% w/v, about 3% w/v, about 3.125% w/v, about 3.25% w/v, about 3.5% w/v, about 3.75% w/v, about 4% w/v, about 4.125% w/v, about 4.25% w/v, about 4.5% w/v, about 4.75% w/v, about 5% w/v or higher, although high concentrations of photo-initiators can be toxic to cells.
Methods other that photo-cross-linking can also be used for preparing hydrogel ionic circuits. For example, cross-linking can be achieved utilizing chemical cross-linking agents, physical cross-linking methods (for example, repeated cycles of freezing and thawing can induce cross-linking of particular polymers), irradiative cross-linking methods, thermal cross-linking methods, ionic cross-linking methods, and the like.
In some embodiments, the circuit comprises an electronically responsive component. The electronically responsive component can be any device, sensor, machine, light, tool, or another circuit that can be activated by an electric current. In some embodiments, the electronically responsive component is a light-emitting diode (LED) or an organic light emitting diode (OLED). Other suitable electronically responsive components include, without limitation, resistors, heaters, energy storage units, low-power display units, and low-power speakers. In some embodiments, the electronically responsive component are cells cultured in the narrowest part of the gap between the salt solution electrode channels.
In some embodiments, the top and bottom of the hydrogel circuit are covered to prevent water evaporation. Covers may be made of any electrical insulating material which itself will not conduct an electric current. Suitable materials include, but are not limited to, acrylic, glass, plastic, biodegradable polymers, ceramic, polypropylene, TeflonTM, nylon, polycarbonate, and polyvinyl chloride. The cover will also include one or more holes or ports to facilitate easy fluid injection and electrical connection with the salt solutions in the channels.
The hydrogel ionic circuits described herein can be assembled into a device. The device can include one or more circuits and a power source. The circuits are connected to the power source via the ports to the salt solution electrode channels. Devices including the circuits described herein may also include one or more electronically responsive comments, such as an LED. The devices may also include an aqueous-based connective interface to connect the circuit to a tissue in vivo or to an in vitro cell culture.
Practical Applications
Circuits and devices described herein may be used to stimulate tissues. The devices and circuits may be fabricated in to skin-mounted electronic stimulators or implantable electronic stimulators. Tissues suitable for stimulation using the devices and circuits described herein include, but are not limited to, muscle tissue (e.g., cardiac muscle, smooth muscle, skeletal muscle), nervous tissues (e.g., brain tissue, spinal cord, nerves), epithelial tissue (e.g., lining of the gastrointestinal tract organs, lining of other hallow organs, surface of the skin), and connective tissue (e.g., fat, tendons).
In some embodiments, circuits and devices described herein may be used to stimulate cardiac tissue and may be fabricated into pacemakers or defibrillators. The pacemakers or defibrillators including the circuits described herein may be implanted into the chest cavity of a subject along with a suitable power source.
In some embodiments, circuits and devices described herein may be used to stimulate skin or skeletal muscle tissue and be fabricated for implantation on or directly below the surface of the skin.
The circuits and devices described herein can also be fabricated into stretchable multi-pixel light-emitting diode (LED)-based display devices that can display an array of Arabic numerals and letters.
The devices and circuits described herein are flexible circuits that are mechanically reconfigurable and it is envisioned that they can be fabricated into skin-mounted electronics that can detect touch.
The term “implantable” as used herein refers to a biocompatible device (e.g., hydrogel ionic circuit-based device) retaining potential for successful placement within a mammal. The expression “implantable device” and expressions of the like as used herein refers to an object implantable through surgery, injection, or other suitable means whose primary function is achieved either through its physical presence or mechanical properties.
Definitions
In this application, unless otherwise clear from context, the term “a” may be understood to mean “at least one.” As used in this application, the term “or” may be understood to mean “and/or.” In this application, the terms “comprising” and “including” may be understood to encompass itemized components or steps whether presented by themselves or together with one or more additional components or steps. Unless otherwise stated, the terms “about” and “approximately” may be understood to permit standard variation as would be understood by those of ordinary skill in the art. Where ranges are provided herein, the endpoints are included. As used in this application, the term “comprise” and variations of the term, such as “comprising” and “comprises,” are not intended to exclude other additives, components, integers or steps.
As used in this application, the terms “about” and “approximately” are used as equivalents. Any numerals used in this application with or without about/approximately are meant to cover any normal fluctuations appreciated by one of ordinary skill in the relevant art. In certain embodiments, the term “approximately” or “about” refers to a range of values that fall within 25%, 20%, 19%, 18%, 17%, 16%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, or less in either direction (greater than or less than) of the stated reference value unless otherwise stated or otherwise evident from the context (except where such number would exceed 100% of a possible value).
The present invention will be more fully understood upon consideration of the following non-limiting Examples. All texts, papers, and patents disclosed herein are hereby incorporated by reference as if set forth in their entirety.
Reference is now made to the following examples, which together with the above descriptions illustrate the invention in a non-limiting fashion.
To generate hydrogel ionic circuits based on salt/PEG ATPS, microchannels with desired conductive patterns were molded into photocrosslinked PEG hydrogels using polydimethylsiloxane (PDMS) molds (
A simple hydrogel ionic display device comprising three LEDs/pixels was fabricated to demonstrate the concept of these hydrogel ionic circuits (
We have studied the response of our hydrogel ionic circuits to different mechanical inputs, including bending, stretching and pressing, using a simple circuit design consisting of one channel filled with saturated sodium sulfate solution (
Taking advantage of the re-programmability of the hydrogel ionic circuits, we designed a hydrogel LED display device that could be activated by mechanical press or touch. This device was prepared with PEG precursor solution containing 20% w/w PEGDMA 8,000 and 1% w/w Irgacure 2959 to achieve low stiffness.
To test the utility of certain provided hydrogel ionic circuits in a biological context, we designed a hydrogel ionic electrode array for localized stimulation of in vitro cultured cells (
PEG hydrogel with 20% w/w PEGDMA 8,000, 20% w/w PEGDA 700, and 1% w/w irgacure 2959 was used for the fabrication of this device to achieve acceptable phase separation with Tyrode's solution. COMSOL simulations (
To confirm the ability of these hydrogel ionic circuits to form seamless bio-interfaces with soft tissues and effect in vivo electrical stimulation, skeletal muscle tissue stimulation experiments were conducted. A hydrogel ionic stimulator was designed with one pair of electrodes (
The injection of electrical current in tissues using conventional electron-conducting electrodes inevitably involves electrochemical reactions at electrode/tissue interface. These reactions induce chemical changes at the tissue site, such as the production of hydronium or hydroxide ions that changes the local pH, which together with charge injection-induced local heating can cause tissue damage (27-29). Here we demonstrate that, in some embodiments, provided hydrogel ionic stimulators reduced these adverse effects due to the high water content of the devices, which dissipates heat, as well as the potential use of pH buffering salts as the salt phase. We injected a constant current of 65 mA at a density of 0.72 A/cm2 into an excised chicken breast for 30 seconds, which is significantly higher than the pain threshold for both dry (0.13 mA/cm2) and hydrogel electrodes (1.38 mA/cm2), but is relevant to the current density applied during electroporation and external defibrillation (16, 30, 31). Hydrogel ionic electrodes, carbon and stainless steel electrodes were tested (
To reduce the pH changes from the current injection induced by electrochemical reactions at the metal electrode/salt solution interface, saturated sodium dibasic phosphate solution was used as the salt phase in the hydrogel ionic electrodes. Current was injected into phosphate buffered saline (PBS)-soaked pH papers for easy assessment of pH changes (
Data presented in
The simulated results were consistent with measured values.
Materials and Methods
Materials and Device Fabrication
Polyethylene glycol dimethacrylate (PEGDMA, molecular weight: 8,000) was purchased from Polysciences (Warrington, Pa., USA). Polyethylene glycol diacrylate (PEGDA, molecular weight: 700), Irgacure 2959, benzophenone, sodium sulfate and sodium dibasic phosphate were purchased from Sigma Aldrich (St. Louis, Mo., USA). Sylgard 184 silicone elastomer kit (PDMS) was purchased from Fisher Scientific (Pittsburgh, Pa., USA). LEDs were purchased from Mouser electronics (Mansfield, Tex., USA). Liquid powder dye (Rit liquid dye) was purchased from local Walmart (Saugus, Mass., USA). Acrylic sheets and very-high-bond (VHB) foam tape were purchased from Mcmaster-Carr (Robbinsville, N.J., USA). Dulbecco's modified eagle medium with nutrient mixture F12 (DMEM/12), fetal bovine serum (FBS), penicillin-streptomycin and Fluo-4 AM calcium stain were purchased from Thermo Fisher Scientific (Grand Island, N.Y., USA). SH-SY5Y cells were purchased from ATCC (Manassas, Va., USA).
The 3-LED display devices, 3-by-5 LED display devices, one of the single-channel devices for cyclic press test, hydrogel ionic electrode array for SH-SY5Y stimulation, hydrogel ionic electrodes for chicken breast stimulation and pH characterization were fabricated using precursor containing 20% w/w PEGDMA 8 k, 20% w/w PEGDA 700, and 1% w/w irgacure 2959. The single-LED device for stretchability demonstration, single-channel devices for testing mechanical responses, one of the single-channel devices for cyclic press test, the LED touch sensors (single and 2-by-3) and the hydrogel ionic stimulators for in vivo muscle stimulation were fabricated using precursor containing 20% w/w PEGDMA 8 k and 1% w/w irgacure 2959.
To fabricate hydrogel ionic circuit devices, PDMS molds with desired conductive patterns (channels for salt solution perfusion) were first created. The patterns were subsequently transferred to PEG hydrogels using photo-crosslinking (34). The PEG hydrogel with channel patterns was bonded to a flat PEG hydrogel using photo-crosslinking to close the channels. It is important to avoid over-exposure when making the molded and the flat PEG hydrogels in order to ensure good bonding strength (35). Acrylic boards of 1.6 mm thick was used to cover the top and bottom of hydrogel ionic circuits to prevent water evaporation. The acrylic boards were coated with a layer of 0.5 mm thick VHB tape, which was treated with 10% w/w benzophenone in ethanol for 2 minutes to ensure good bonding with PEG hydrogels (36). Access holes were laser cut on the top acrylic board for easy fluid injection and electrical connections. The channels were perfused with salt solution to establish paths with high conductivity.
Device Characterization
To evaluate the long-term stability of salt/PEG phase separation, photocrosslinked PEG hydrogel discs were soaked in various ionic media and their resistivity was tested before soaking and at days 3, 7, 10, and 14. Four PEG hydrogel formulas were tested: 1) 5% w/w PEGDMA 8 k and 1% w/w irgacure 2959; 2) 20% w/w PEGDMA 8 k and 1% w/w irgacure 2959; 3) 20% w/w PEGDMA 8 k, 20% w/w PEGDA 700 and 1% w/w irgacure 2959; and 4) 20% w/w PEGDMA 8 k, 40% w/w PEGDA 700 and 1% w/w irgacure 2959. PEG hydrogels based on formula 1were tested with Tyrode's buffer, 5% w/w Na2HPO4 solution, DMEM and 5% w/w Na2SO4 solution to demonstrate that two-phase cannot be formed if the concentrations of PEG in hydrogels and/or the concentration of ionic media do not exceed threshold. PEG hydrogels based on formula 2-4 were tested with Tyrode's buffer, saturated Na2HPO4 solution, DMEM and saturated Na2SO4 solution to demonstrate successful phase separation. The resistivity of the hydrogel discs and the media were obtained using an Agilent 4284A LCR meter.
To assess the transparency of the PEG materials, 1 mm thick PEG hydrogel discs were fabricated at the bottom of a 96-well plate. The optical absorbance was measured from 400 to 700 nm at 50 nm intervals using a plate reader (SpectraMax M2, Molecular Devices). The transmittance was calculated from the absorbance (percent transmittance=10(2-absorbance)).
To characterize the responses of hydrogel ionic circuits to mechanical stimulations, devices with single salt channel were pressed using a rheometer (TA instruments), stretched or bent, and the channel resistance changes were recorded using the LCR meter. The compressive strength of PEG hydrogels was measured using a universal mechanical testing system (Instron 3366).
In Vitro Cellular Electrical Stimulation using Hydrogel Ionic Electrode Array
SH-SY5Y cells were cultured in DMEM/F12 supplemented with 10% FBS and 1% antibiotics at 37° C., 5% CO2. One day prior to experiment, SH-SY5Y cells were trypsinized and transferred to an OneWell tissue culture plate (Greiner) at 80,000 cells/cm2. The cells were cultured for at least 24 hours to allow sufficient attachment. On the day of experiment, the cells were stained with Fluo-4 AM calcium dye (2.5 μg/ml in serum-free cell medium) for 45 minutes.
After staining, the cells were rinsed with Tyrode's buffer, which was also used as the buffer for the following stimulation experiments. The cells were stimulated with a positive-only pulsed signal with 1 Hz frequency, 2 millisecond pulse width and 3.6 V/cm field strength. The pulsed signal was generated from a data acquisition system (USB-6221, National Instruments) and amplified using a custom-built power amplifying circuit. The cells were stimulated for 30 minutes and the changes of intracellular calcium concentrations at both stimulated spots and unstimulated spots were monitored using fluorescent microscopy (Keyence).
In Vivo Muscle Electrical Stimulation using Hydrogel Ionic Stimulator
All animal protocols were approved by the Institutional Animal Care and Use Committee (IACUC) at Tufts University. Male Sprague Dawley rats (300 grams) were purchased from Charles River Laboratories. The rats were anesthetized with isoflurane (3 to 5%) and their hind legs were shaved and prepped for surgery. Animals were placed in the prone position on a customized operating table enabling the fixation of the knee joint. The tibialis anterior (TA) muscles were exposed via a skin incision with a scalpel blade. Bipolar hydrogel ionic stimulators and standard gold electrodes (control) with a 2 mm electrode separation were used to electrically stimulate the muscle tissues. The stimulation signals (1 Hz positive-only pulsed signal with 2 millisecond pulse width or 50 Hz positive-only pulsed signal with 40 microsecond pulse width, with a voltage ranging from 0.9 V to 4.0 V) were generated from a data acquisition system (USB-6221, National Instruments) and amplified using a custom-built power amplifying circuit.
Functional assessment of the hydrogel ionic stimulators and gold electrodes to stimulate muscle tissues was conducted by measuring twitch (1 Hz) and tetanic (50 Hz) forces. Prior to stimulation the foot was anchored at the cleft between digits 1 and 2 to a force transducer using nylon ligature. Either the hydrogel ionic stimulator or gold electrodes were placed in contact with the exposed muscle to stimulate contraction. The force of each contraction was measured and recorded using LabChart 7 (ADinstruments).
Statistical Analysis
IBM SPSS Statistics 22 Software (New York, USA) was used to perform One Way ANOVA for statistical analysis (p<0.05) in order to evaluate the significance of localized electrical stimulation for in vitro cell cultures. Post-hoc comparison of means was performed by Tukey HSD test, and post-hoc procedures and statistical significance were considered at p<0.05. All statistics were performed using 3 replicates. To evaluate the ability of electrodes to stimulate muscle contraction in vivo, a Student's t-test was performed between the two electrode types (hydrogel ionic and metal). Differences between the conditions were considered significant at p<0.05 (n≥1).
This application claims priority to U.S. Provisional Patent Application No. 62/569,313, filed Oct. 6, 2017, which is incorporated by reference as if set forth in its entirety.
Number | Date | Country | |
---|---|---|---|
62569313 | Oct 2017 | US |